The highly anticipated 3rd Edition of PACK.Nxt returns to The Lalit in Mumbai on 16th December 2025, the only dedicated event on Smart & Sustainable Packaging in India.
Lupin Manufacturing Solutions (LMS), a fully owned subsidiary of a multinational pharmaceutical company Lupin, has also established a separate Oncology Block in its Vizag plant in India. This high-capacity unit will increase the end-to-end CDMO...
The Pan American Health Organization (PAHO) has placed a $4.75 million (Rs 41 crore) order with Panacea Biotec to supply the Easyfive TT vaccine under a long-term contract
BASF and Beyond Suncare express their approval of the World Health Organization's (WHO) decision to incorporate broad-spectrum sunscreen with a high SPF into the 24th edition of the Model List of Essential Medicines (EML) and the 10th edition of the
Indian pharma companies Cipla, Natco Pharma, Hetero Labs, and Annora Pharma have achieved a breakthrough in China after securing key bids to supply generic drugs under the country’s latest volume-based procurement (VBP) program...
Ascelia Pharma AB (publ), a biotech focused on improving the life of people living with rare cancer conditions, announced the filing of a new patent application for its first-in-class orphan liver imaging drug Orviglance
Tata 1mg, one of India’s leading e-pharmacy platforms, has entered into a strategic alliance with ClickPost, a logistics intelligence company, to enhance and automate its medicine delivery network through AI-powered Performance-Based Courier
Novo Nordisk India partners with Emcure Pharma to launch Poviztra, expanding access to semaglutide 2.4 mg for safe, effective weight loss across India.
Pfizer has clinched a major victory in the race for next-generation obesity treatments, signing a deal to acquire development-stage drugmaker Metsera Inc. after outbidding rival Novo Nordisk, the maker of Ozempic and Wegovy...
Eli Lilly’s anti-obesity drug Mounjaro has become India’s highest-selling pharmaceutical by value in October, with sales touching ?100 crore ($11.38 million). The surge reflects the growing demand for anti-obesity medications in a country...